NeuroTrigger

Wearable Muscle Re-eductaion Stimulator

Health Tech & Life Sciences
Active
Seed Tel Aviv-Yafo, Israel Founded 2018
Last updated 2026-06-18
Total raised
$4.1M
Last: 2025-04
Stage
Seed
Founded
2018
Headcount
6
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

NeuroTrigger develops the next generation powered muscle re-education system. This wearable and lightweight system is composed of a a rechargeable stimulator and a pre-gelled Y-shaped electrode, easily connected by a magnetic flap. Electrical pulses are generated in the stimulator and transmitted to the body through the electrodes, eliciting repeated contracting of muscles. Re-educating muscles (anywhere in the body, including musculature of the face) is important for improving or facilitating muscle performance for either maintaining or increasing muscle’s range of motion and prevention or retardation of disuse atrophy. A unique mobile phone application communicates with the wearable stimulator via Bluetooth communication, enabling the user, care giver or technician to monitor stimulator status and, where permitted adjust various parameters.

The company received FDA for its non-invasive muscle stimulation system (NTB).

Funding history · 5 rounds · $4.1M total

2025-04
$520K
2023-07
Grant $800K
2023-07
2022-01
$1.0M

Q&A

What is NeuroTrigger's primary business?
NeuroTrigger develops a wearable muscle re-education stimulator system designed to improve or facilitate muscle performance, maintain or increase range of motion, and prevent disuse atrophy.
When was NeuroTrigger founded?
NeuroTrigger was founded in June 2018.
How many employees does NeuroTrigger currently have?
NeuroTrigger has 1-10 employees.
What is NeuroTrigger's total funding to date?
NeuroTrigger has raised a total of $4,120,000 USD.
When was NeuroTrigger's most recent funding round and what was the amount?
NeuroTrigger's most recent funding round occurred in April 2025, raising $520,000 USD.
Which investors participated in NeuroTrigger's July 2023 funding rounds?
In July 2023, NeuroTrigger received funding from Merage Institute and a grant from BIRD Foundation.
What regulatory approval has NeuroTrigger received for its product?
NeuroTrigger has received FDA approval for its non-invasive muscle stimulation system (NTB).
Who are the co-founders of NeuroTrigger?
The co-founders of NeuroTrigger are Shachar Paz (Co-founder & CTO), Michal Marks (Co-founder & General Counsel), and Assaf Deutsch (Co-founder & VP R&D).

Team · 3

Founder · Co-founder & CTO
LinkedIn ↗
Founder · Co-founder & General Counsel
LinkedIn ↗
Founder · Co-founder & VP R&D
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical Devices
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2BB2C

Highlights

1 PatentsVerified

Tags

neuro-stimulationpatientsmedical-deviceswearablemedical-technologieswearablenon-invasive
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)